Kodiak Sciences Inc
Long

$KOD:NASDAQ - KODIAK SCIENCES - Up 950% over 12 months

235
Kodiak has had an amazing run over the last year but has been ranging sideways for the last couple of months. With a Bollinger breakout to the upside it could be worth a look.

Kodiak Sciences, Inc. is a a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline include KSI-301 for wet AMD; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD; and KSI-401 for dry AMD.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.